(Hypertension. 1999;34:795-801.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the MRC Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montréal, Montréal, Quebec, Canada.
Correspondence to Ernesto L. Schiffrin, MD, PhD, FRCPC, Clinical Research Institute of Montreal, 110 Avenue des Pins Ouest, Montréal, Québec, Canada H2W 1R7. E-mail schiffe{at}ircm.qc.ca
AbstractThe cardiac
abnormalities associated with hypertension include left
ventricular hypertrophy and vascular changes.
The latter may affect the cardiac microvasculature and predispose to
myocardial ischemia. To test the hypothesis that endothelin-1
contributes to changes in the microcirculation of the heart, we studied
cardiac microvessels of the deoxycorticosterone acetatesalt
(DOCA-salt) model of hypertension in the rat, in which the endothelin
system is activated, and the effect of the endothelin-A
(ETA) subtypeselective endothelin receptor
antagonist A-127722. A-127722 (30 mg ·
kg-1 · d-1) was administered for 4
weeks. Arterioles (
20 µm in lumen diameter) were identified in
the myocardium by use of immunolabeling with an
antismooth muscle
-actin antibody, and capillaries with an
anti-laminin antibody with nuclear counterstaining by nuclear fast red.
Systolic blood pressure was 103±1.6 mm Hg in
unilaterally nephrectomized rats (UniNx), 202±3.2 mm Hg in
DOCA-salt (P<0.01 versus UniNx), and 182±3.1
mm Hg in ETA antagonisttreated DOCA-salt
(P<0.01 versus DOCA-salt or UniNx). Arteriolar and
capillary densities were altered significantly in the subendocardial
myocardium but not in the subepicardial
myocardium of the left ventricle. Arteriolar density per
square millimeter was 18.1±1.48 in UniNx, 31.9±3.26 in DOCA-salt
(P<0.01 versus UniNx), and 24.2±1.36 in
ETA antagonisttreated DOCA-salt (P<0.05
versus DOCA-salt or UniNx). Capillary density per square millimeter was
2395±148 in UniNx, 1576±107 in DOCA-salt (P<0.01
versus UniNx), and 1982±31 in ETA antagonisttreated
DOCA-salt (P<0.01 versus DOCA-salt or UniNx). In
conclusion, in DOCA-salt hypertensive rats, subendocardial arteriolar
growth and capillary rarefaction were observed in the left
ventricular myocardium, and both were partially
corrected by ETA receptor antagonism. This suggests a role
for endothelin-1 in cardiac arteriolar growth and capillary
rarefaction, which may have pathophysiological
implications by contributing to myocardial ischemia in
hypertension.
Key Words: microcirculation arterioles growth capillaries hypertension, experimental myocardium ischemia
This article has been cited by other articles:
![]() |
M. Iemitsu, S. Maeda, S. Jesmin, T. Otsuki, and T. Miyauchi Exercise training improves aging-induced downregulation of VEGF angiogenic signaling cascade in hearts Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1290 - H1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kobayashi, F. A. DeLano, and G. W. Schmid-Schonbein Oxidative Stress Promotes Endothelial Cell Apoptosis and Loss of Microvessels in the Spontaneously Hypertensive Rats Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2114 - 2121. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iglarz, R. M. Touyz, F. Amiri, M.-F. Lavoie, Q. N. Diep, and E. L. Schiffrin Effect of Peroxisome Proliferator-Activated Receptor-{alpha} and -{gamma} Activators on Vascular Remodeling in Endothelin-Dependent Hypertension Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 45 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Giulumian, M. M. Molero, V. B. Reddy, J. S. Pollock, D. M. Pollock, and L. C. Fuchs Role of ET-1 receptor binding and [Ca2+]i in contraction of coronary arteries from DOCA-salt hypertensive rats Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1944 - H1949. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Schiffrin Role of Endothelin-1 in Hypertension Hypertension, October 1, 1999; 34(4): 876 - 881. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |